DỮ LIỆU BÁO CÁO THƯỜNG NIÊN
CÁC CÔNG TY NIÊM YẾT NƯỚC NGOÀI

Báo cáo thường niên năm 2019 của Cleveland Biolabs, Inc.

Cleveland BioLabs, Inc. is a biotechnology focused on developing biodefense, tissue protection and cancer treatment drugs based on concept of modulation of cell death for therapeutic benefit. CBLI's pipeline includes products from two primary families of compounds: protectans and curaxins. It is developing protectans as drug candidates that protect healthy tissues from acute stresses, such as , chemotherapy and ischemia. Curaxins are being developed as anticancer agents that could act as mono-therapy drugs or in combination with other existing anticancer therapies.

TÊN CÔNG TY / COMPANY
Cleveland Biolabs, Inc.

SÀN CHỨNG KHOÁN / STOCK EXCHANGE
NASDAQ (US)

MÃ CHỨNG KHOÁN / TICKER
CBLI

KỲ BÁO CÁO
2019

NGÀNH / INDUSTRY
Research Services

LĨNH VỰC / SECTOR
Services